Price target
13.230.000.00%
The 1 analyst offering 1 year price forecasts for 2315 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 1 analyst giving stock ratings to 2315 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
2315 EPS for the last quarter is −0.14 HKD despite the estimation of −0.13 HKD. In the next quarter EPS is expected to reach 0.01 HKD. Track more of BIOCYTOGEN PHARMACEUTICALS (BEIJING financials and stay on top of what is up with the company.
In the next quarter BIOCYTOGEN PHARMACEUTICALS (BEIJING revenue is expected to reach 577.07 M HKD. Check out BIOCYTOGEN PHARMACEUTICALS (BEIJING revenue and earnings and make informed decisions.
According to analysts, 2315 price target is 13.23 HKD with a max estimate of 13.23 HKD and a min estimate of 13.23 HKD. Check if this forecast comes true in a year, meanwhile watch BIOCYTOGEN PHARMACEUTICALS (BEIJING stock price chart and keep track of the current situation with 2315 news and stock market news.